NALP1 in vitiligo-associated multiple autoimmune disease

New England Journal of Medicine

Volumn 356, Issue 12, 2007, Pages 1216-1225

  Jin, Ying ^a   Mailloux, Christina M ^a   Gowan, Katherine ^a   Riccardi, Sheri L ^a   Laberge, Greggory ^a   Bennett, Dorothy C ^c   Fain, Pamela R ^a,b   Spritz, Richard A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; CHROMOSOME 17P; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; FAMILY ASSESSMENT; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MUTATOR GENE; NALP1 GENE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; VITILIGO;

EID: 33947497237     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa061592     Document Type: Article

References (38)

1. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nat Med 2001;7:899-905.
2. NIH Autoimmune Diseases Coordinating Committee. Progress in autoimmune diseases research. Bethesda, MD: National Institutes of Health, 2005. (Accessed February 21, 2007, at http://www.niaid.nih.gov/dait/pdf/ADCC_Final.pdf.)
3. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997;84:223-43.
4. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev 2003;2:119-25.
5. Walsh SJ, Rau LM. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health 2000;90:1463-6.
6. Brand O, Gough S, Heward J. HLA, CTLA-4, and PTPN22: the shared genetic master-key to autoimmunity? Expert Rev Mol Med 2005;7:1-15.
7. Gregersen PK, Behrens TW. Genetics of autoimmune diseases - disorders of immune homeostasis. Nat Rev Genet 2006;7:917-28.
8. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their relatives. Pigment Cell Res 2003;16:208-14.
9. Laberge G, Mailloux CM, Gowan K, et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res 2005;18:300-5.
10. Spritz RA, Gowan K, Bennett DC, Fain PR. Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet 2004;74:188-91.
11. Nath SK, Kelly JA, Namjou B, et al. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am J Hum Genet 2001;69:1401-6.
12. Johansson CM, Zunec R, Garcia MA, et al. Chromosome 17p12-q11 harbors susceptibility loci for systemic lupus erythematosus. Hum Genet 2004;115:230-8.
13. Nordlund JJ. Vitiligo vulgaris. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Oetting WS, Ortonne J-P, eds. The pigmentary system. 2nd ed. Malden, MA: Blackwell Publishing, 2006:551-98.
14. Martin ER, Monks SA, Warren LL, Kaplan NL. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 2000;67:146-54.
15. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM. Family-based tests for association haplotypes with general phenotype data: application to asthma genetics. Genet Epidemiol 2004;26:61-9.
16. Bryson K, McGuffin LJ, Marsden RL, et al. Protein structure prediction servers at University College London. Nucleic Acids Res 2005;33(Web Server issue):W36-W38.
17. Schug J, Overton GC. TESS: Transcription Element Search system. Technical report CBIL-TR-1997-1001-v0.0. Philadelphia: University of Pennsylvania, 1997. (Accessed February 21, 2007, at http://www.cbil.upenn.edu/cgi-bin/tess/tess.)
18. Loots GG, Ovcharenko I. rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res 2004;32(Web Server Issue):W217-W221.
19. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
20. Abecasis GR, Cherny SS, Cookson WOC, Cardon LR. Merlin - rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002;30:97-101.
21. Cordell HJ, Clayton DG. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 2002;70:124-41.
22. Hlaing T, Guo R-F, Dilley KA, et al. Molecular cloning and characterization of DEFCAP-L and -S, two isoforms of a novel member of the mammalian Ced-4 family of apoptosis proteins. J Biol Chem 2001;276:9230-8.
23. Kufer TA, Fritz JH, Philpott DJ. NACHT-LRR proteins (NLRs) in bacterial infection and immunity. Trends Microbiol 2005;13:381-8.
24. Petrilli V, Papin S, Tschopp J. The inflammasome. Curr Biol 2005;15:R581.
25. Su AI, Wiltshire T, Batalov S, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 2004;101:6062-7.
26. Kummer JA, Broekhuizen R, Everett H, et al. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues, suggesting a site-specific role in the inflammatory response. J Histochem Cytochem (in press).
27. Tu C-X, Gu J-S, Lin X-R. Increased interleukin-6 and granulocyte- macrophage colony stimulating factor levels in the sera of patients with non-segmental vitiligo. J Dermatol Sci 2003;31:73-8.
28. Chu ZL, Pio F, Xie ZH, et al. A novel enhancer of the Apaf1 apoptosome involved in cytochrome c-dependent caspase activation and apoptosis. J Biol Chem 2001;276:9239-45.
29. Liu F, Lo CF, Ning X, et al. Expression of NALP1 in cerebellar granule neurons stimulates apoptosis. Cell Signal 2004;16:1013-21.
30. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
31. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
32. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet 2001;29:19-20.
33. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001;29:301-5.
34. Aganna E, Martinon F, Hawkins PN, et al. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 2002;46:2445-52.
35. Feldman J, Prieur AM, Quartier P, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002;71:198-203.
36. Hawkins PN, Lachmann HJ, McDermott MF. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med 2003;348:2583-4.
37. Goldbach-Mansky R, Dailey NJ, Canna SW, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition. N Engl J Med 2006;355:581-92.
38. Stack JH, Beaumont K, Larsen PD, et al. IL-converting enzyme/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients. J Immunol 2005;175:2630-4.